Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3
2004 StandoutNobel
Genetic Immunization
1996
Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization
2001
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Modulating gene expression using DNA vaccines with different 3′-UTRs influences antibody titer, seroconversion and cytokine profiles
2003
Hepatitis C Virus Infection
2001 Standout
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
2010 StandoutNobel
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
1998
Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines
1999
MHC Class I Antigen Processing Pathways
1997
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
1999
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
2005 StandoutNobel
Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting
2003
Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C
1999
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Human Clinical Trials of Plasmid DNA Vaccines
2005
A new foreign policy: MHC class I molecules monitor the outside world
1996
A Pilot Clinical Trial of HIV Antigen-Pulsed Allogeneic and Autologous Dendritic Cell Therapy in HIV-Infected Patients
1998
Biosensing with plasmonic nanosensors
2008 Standout
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Gene vaccination with naked plasmid DNA: mechanism of CTL priming.
1996
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
CD4+T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
2001
The Detection and Discovery of Glycan Motifs in Biological Samples Using Lectins and Antibodies: New Methods and Opportunities
2015
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
HIV-1-Specific CTL Responses Primed In Vitro by Blood-Derived Dendritic Cells and Th1-Biasing Cytokines
1999
Induction of Primary Human CD8+ T Lymphocyte Responses In Vitro Using Dendritic Cells
1999
Protective Antiviral Cytotoxic T Cell Memory Is Most Efficiently Maintained by Restimulation Via Dendritic Cells
1999
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Quantitative analysis of the immunopotency of genetically transfected dendritic cells
1998
Localized Surface Plasmon Resonance Sensors
2011 Standout
Antigen presentation to cytotoxic T lymphocytes in vivo.
1995
Multiple Label-Free Detection of Antigen−Antibody Reaction Using Localized Surface Plasmon Resonance-Based Core−Shell Structured Nanoparticle Layer Nanochip
2006
Dendritic Cells Efficiently Induce Protective Antiviral Immunity
1998
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo
2003 StandoutNobel
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Uses of Dendrimers for DNA Microarrays
2006
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference
2002 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Immunological Memory and Protective Immunity: Understanding Their Relation
1996 StandoutScience
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
1999
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
1996
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Constitutive class I-restricted exogenous presentation of self antigens in vivo.
1996 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Richard Rouse being referenced
Induction of Protective Immunity against Herpes Simplex Virus with DNA Encoding the Immediate Early Protein ICP 27
1995
Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses
1995
Protein Microarrays: Challenges and Promises
2002
Development of a microarray assay that measures hybridization stoichiometry in moles
2004
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes
1995
Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins
1994
Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization
2000
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells
1997
Advances in Lectin Microarray Technology: Optimized Protocols for Piezoelectric Print Conditions
2013